A detailed history of Total Clarity Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Total Clarity Wealth Management, Inc. holds 6,145 shares of ABBV stock, worth $1.23 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
6,145
Previous 5,923 3.75%
Holding current value
$1.23 Million
Previous $1.02 Million 19.51%
% of portfolio
0.41%
Previous 0.36%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $36,372 - $44,251
222 Added 3.75%
6,145 $1.21 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $5,417 - $6,326
35 Added 0.59%
5,923 $1.02 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $76,074 - $86,679
476 Added 8.8%
5,888 $1.07 Million
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $146,681 - $165,198
-1,066 Reduced 16.46%
5,412 $838,000
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $8,015 - $9,279
60 Added 0.93%
6,478 $965,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $81,228 - $101,083
-613 Reduced 8.72%
6,418 $864,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $4,193 - $4,829
-29 Reduced 0.41%
7,031 $1.12 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $62,516 - $74,973
452 Added 6.84%
7,060 $1.14 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $10,468 - $12,006
78 Added 1.19%
6,608 $887,000
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $8,807 - $11,197
64 Added 0.99%
6,530 $1 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $11,350 - $14,082
-86 Reduced 1.31%
6,466 $1.05 Million
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $55,756 - $70,547
519 Added 8.6%
6,552 $887,000
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $20,109 - $22,827
189 Added 3.23%
6,033 $651,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $25,986 - $28,950
247 Added 4.41%
5,844 $658,000
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $3,478 - $3,829
-34 Reduced 0.6%
5,597 $606,000
Q4 2020

Jan 20, 2021

SELL
$80.49 - $108.67 $12,797 - $17,278
-159 Reduced 2.75%
5,631 $603,000
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $21,391 - $25,106
-249 Reduced 4.12%
5,790 $507,000
Q2 2020

Jul 15, 2020

BUY
$73.37 - $98.18 $4,622 - $6,185
63 Added 1.05%
6,039 $593,000
Q1 2020

Apr 24, 2020

BUY
$64.5 - $97.79 $56,889 - $86,250
882 Added 17.31%
5,976 $455,000
Q4 2019

Feb 27, 2020

BUY
$72.13 - $90.25 $367,430 - $459,733
5,094 New
5,094 $451,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.